Related Experiment Videos
[Treatment of acute myocardial infarct]
1I. interná klinika Lekárskej fakulty Univerzity Komenského a Fakultnej nemocnice v Bratislave, Slovakia.
Insights
Standard medical therapy for acute myocardial infarction (AIM) prioritizes thrombolytic therapy due to thrombotic occlusion. Early intravenous administration of acetylsalicylic acid, betablockers, and ACE inhibitors improves survival.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Acute myocardial infarction (AIM) management has evolved with advancements in therapeutic procedures.
- Coronary artery thrombotic occlusion is the primary cause of AIM.
Purpose:
- To present the current standard medical therapy for acute myocardial infarction.
- To highlight key pharmacological interventions and their optimal application.
Summary:
- Thrombolytic therapy is central to AIM treatment.
- Acetylsalicylic acid, betablockers, and ACE inhibitors are crucial, with early intravenous administration recommended.
- Symptomatic treatments include analgesics, nitrates, and magnesium; routine antiarrhythmics are not advised.
Impact:
- This approach aims to reduce mortality and improve patient outcomes in acute myocardial infarction.
- Highlights the importance of timely and targeted pharmacological interventions.
Abstract:
On the basis of the development of therapeutical procedures in acute myocardial infarction (AIM) the author offers the current standpoint to the standard medicamentous therapy of this disease. As AIM is caused by thrombotic occlusion of the coronary artery, the main therapeutical position is ascribed to the thrombolytic therapy. An important position is ascribed to acetylsalicylic acid and betablockers. The optimal application is intravenous administration at an early stage of the disease. The ISIS-4 study displayed a beneficial impact on mortality including ACE inhibitors. The symptomatic therapy includes analgetics administered at an early stage of the disease, nitrates and magnesium. Antiarrhythmics are not to be applied in a routine pattern. Cardiogenic shock can be treated exclusively by invasive therapeutical intervention (e.g. direct PTCA or emergent bypass).